Industry News

Ourself’s Clinical Data Published in Dermatologic Surgery

The publication highlights that Tiered-Release Vesicles have the potential to "revolutionize" skincare by enabling the delivery of large, bioactive molecules directly into the epidermis and dermis.

Author Image

By: Lianna Albrizio

Associate Editor

Skincare brand Ourself announced that clinical data evaluating its patented delivery technology, Tiered-Release Vesicles (TRVs), was published in Dermatologic Surgery, the official journal of the American Society for Dermatologic Surgery. The publication highlights that TRVs have the potential to “revolutionize” skincare by enabling the delivery of large, bioactive molecules directly into the epidermis and dermis. The Ourself delivery method promises to reshape the way we care for...

Continue reading this story and get 24/7 access to Happi for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Happi Newsletters